{"id":"https://openalex.org/W6531846","doi":"https://doi.org/10.3760/cma.j.issn.0253-2727.2014.05.003","title":"[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].","display_name":"[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].","alternate_titles":[],"publication_year":2014,"publication_date":"2014-05-01","ids":{"openalex":"https://openalex.org/W6531846","doi":"https://doi.org/10.3760/cma.j.issn.0253-2727.2014.05.003","mag":"6531846","pmid":"https://pubmed.ncbi.nlm.nih.gov/24857206"},"language":"zh","primary_location":{"id":"pmid:24857206","doi":"https://doi.org/10.3760/cma.j.issn.0253-2727.2014.05.003","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24857206","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","raw_type":"English Abstract"},"parent_works":[],"lineage":["https://openalex.org/W6531846"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100352718","display_name":"Feng Chen","orcid":"https://orcid.org/0000-0002-7092-8483","observed_orcids":["https://orcid.org/0000-0002-7092-8483"]},"institutions":[{"id":"https://openalex.org/I154099455","display_name":"Shandong University","ror":"https://ror.org/0207yh398","country_code":"CN","type":"education","lineage":["https://openalex.org/I154099455"]},{"id":"https://openalex.org/I4210161528","display_name":"Qilu Hospital of Shandong University","ror":"https://ror.org/056ef9489","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210161528"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Feng Chen","raw_affiliation_strings":["Department of Hematology, Qilu Hospital, Shandong University, Ji'nan 250012, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Qilu Hospital, Shandong University, Ji'nan 250012, China","institution_ids":["https://openalex.org/I154099455","https://openalex.org/I4210161528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101840274","display_name":"Jingxia Wang","orcid":"https://orcid.org/0000-0001-8055-7957","observed_orcids":["https://orcid.org/0000-0001-8055-7957"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingxia Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102586544","display_name":"Ming Hou","orcid":"https://orcid.org/0009-0008-6504-1563","observed_orcids":["https://orcid.org/0009-0008-6504-1563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Hou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103679446","display_name":"Hongguo Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hongguo Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052129613","display_name":"Enqin Yang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Enqin Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112145526","display_name":"Xuehong Ran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuehong Ran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007537683","display_name":"Minglin Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Minglin Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057215700","display_name":"Wenzheng Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wenzheng Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113966102","display_name":"Ruirong Xu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruirong Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Zhencheng Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhencheng Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004465845","display_name":"Kehong Bi","orcid":"https://orcid.org/0000-0003-3154-5735","observed_orcids":["https://orcid.org/0000-0003-3154-5735"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kehong Bi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100327835","display_name":"Xin Wang","orcid":"https://orcid.org/0000-0001-8051-1481","observed_orcids":["https://orcid.org/0000-0001-8051-1481","https://orcid.org/0000-0001-5457-5799"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xin Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100455550","display_name":"Guoqiang Liu","orcid":"https://orcid.org/0000-0003-4373-5376","observed_orcids":["https://orcid.org/0000-0003-4373-5376"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guoqiang Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100713748","display_name":"Sheng Yang","orcid":"https://orcid.org/0000-0003-4226-2159","observed_orcids":["https://orcid.org/0000-0003-4226-2159","https://orcid.org/0009-0009-5248-3466"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sheng Yang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108727659","display_name":"Jin Fan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jin Fan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100322864","display_name":"Lingling Wang","orcid":"https://orcid.org/0000-0002-2399-7646","observed_orcids":["https://orcid.org/0000-0002-2399-7646"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lingling Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1772,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.49341772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"35","issue":"5","first_page":"388","last_page":"392"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pirarubicin","display_name":"pirarubicin","score":0.8629999756813049},{"id":"https://openalex.org/keywords/mitoxantrone","display_name":"mitoxantrone","score":0.9850000143051147},{"id":"https://openalex.org/keywords/relapsed-acute-myeloid-leukemia","display_name":"relapsed acute myeloid leukemia","score":0.9089999794960022},{"id":"https://openalex.org/keywords/refractory-acute-myeloid-leukemia","display_name":"refractory acute myeloid leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.8379999995231628},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9470000267028809},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7400000095367432},{"id":"https://openalex.org/keywords/transfusion-requirements","display_name":"transfusion requirements","score":0.703000009059906}],"concepts":[{"id":"https://openalex.org/C2776085618","wikidata":"https://www.wikidata.org/wiki/Q3905585","display_name":"Pirarubicin","level":3,"score":0.84882652759552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8088128566741943},{"id":"https://openalex.org/C2780923524","wikidata":"https://www.wikidata.org/wiki/Q239426","display_name":"Mitoxantrone","level":3,"score":0.7964931726455688},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.7602319717407227},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6951278448104858},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.6450306177139282},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6304589509963989},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5751163959503174},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.564753532409668},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.48104456067085266},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.45388680696487427},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4432838559150696},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.39758795499801636},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003609","descriptor_name":"Dactinomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:24857206","doi":"https://doi.org/10.3760/cma.j.issn.0253-2727.2014.05.003","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24857206","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","raw_type":"English Abstract"},{"id":"mag:6531846","doi":"https://doi.org/10.3760/cma.j.issn.0253-2727.2014.05.003","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24857206","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2390728050","https://openalex.org/W2389211016","https://openalex.org/W2410447637","https://openalex.org/W2376638942","https://openalex.org/W2369114238","https://openalex.org/W2911895816","https://openalex.org/W2368533788","https://openalex.org/W3016914185","https://openalex.org/W2556676341","https://openalex.org/W2417640141"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"compare":[2],"the":[3,8,16,64,90,114,118,140,160,164],"efficacy":[4,58],"and":[5,13,59,132,148,167],"toxicity":[6,60,134],"of":[7,18,95,143],"chemotherapeutic":[9],"regimen":[10,47,51,174],"containing":[11],"pirarubicin":[12],"mitoxantrone":[14],"on":[15,79,86,104,151],"treatment":[17],"relapsed":[19,40,184],"or":[20,41,185],"refractory":[21,42,186],"acute":[22],"myeloid":[23],"leukemia":[24],"(AML)":[25],"in":[26,128,181],"adults.":[27],"METHODS:":[28],"In":[29],"this":[30,71],"open":[31],"prospective":[32],"multicentre":[33],"study,":[34],"we":[35],"randomly":[36],"assigned":[37],"patients":[38,69,182],"with":[39,89,109,183],"AML":[43],"to":[44],"receive":[45],"TAE":[46,80,105,152,173],"(pirarubicin+cytarabine+etoposide)":[48],"versus":[49,84,97],"MAE":[50,87],"(mitoxantrone":[52],"+":[53,55],"cytarabine":[54],"etoposide).":[56],"The":[57,74,100,123],"were":[61,125,135,157],"compared":[62],"between":[63,113,159],"two":[65,115,161],"groups.":[66,130],"RESULTS:":[67],"56":[68],"entered":[70],"clinical":[72],"trial.":[73],"complete":[75],"remission":[76],"(CR)":[77],"rate":[78],"arm":[81,88,106],"was":[82,102],"79.0%":[83],"55.6%":[85],"overall":[91,119,165],"response":[92,120],"(OR)":[93,121],"rates":[94],"86.8%":[96],"88.9%,":[98],"respectively.":[99],"CR":[101],"higher":[103],"(P=0.035)":[107],"but":[108],"no":[110],"significant":[111,155],"difference":[112],"groups":[116,162],"regarding":[117,163],"rate.":[122],"regimens":[124],"well":[126],"tolerated":[127],"both":[129],"Hematologic":[131],"non-hematologic":[133],"similar":[136],"except":[137],"relatively":[138],"lower":[139],"mean":[141],"dosage":[142],"G-CSF,":[144],"red":[145],"blood":[146],"cells":[147],"platelets":[149],"transfusion":[150],"arm.":[153],"No":[154],"differences":[156],"seen":[158],"survival":[166,170],"relapse":[168],"free":[169],"rates.":[171],"CONCLUSION:":[172],"might":[175],"be":[176],"an":[177],"effective":[178],"salvage":[179],"therapy":[180],"AML.":[187]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6531846","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
